▶ 調査レポート

世界の乳房画像市場(~2027):技術別、エンドユーザー別、地域別

• 英文タイトル:Breast Imaging Market Research Report by Technology, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の乳房画像市場(~2027):技術別、エンドユーザー別、地域別 / Breast Imaging Market Research Report by Technology, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2302F0009資料のイメージです。• レポートコード:MRC2302F0009
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、241ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査レポートでは、2021年に4,120.18百万ドルであった世界の乳房画像市場規模が、2022年に4,483.94百万ドルになり、2027年には6,912.12百万ドルまで、年平均9.00%で成長すると予測しています。本レポートでは、乳房画像の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別(電離乳房イメージング技術、非電離乳房イメージング技術)分析、エンドユーザー別(診断センター、病院、乳房治療センター)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況など、以下の構成でお届けします。なお、本書には、Aurora Imaging Technology, Inc.、CMR Naviscan Corporation、Delphinus Medical Technologies, Inc.、Dilon Technologies, Inc.、Fujifilm Holdings Corporation、GE Healthcare、Hologic, Inc.、KUB Technologies Inc.、Micrima Limited、Philips Healthcare、Planmed Oy、Shimadzu Corporation、Siemens Healthineers AG、Sonociné, Inc.、SuperSonic Imagine SAなどの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の乳房画像市場規模:技術別
- 電離乳房イメージング技術における市場規模
- 非電離乳房イメージング技術における市場規模
・世界の乳房画像市場規模:エンドユーザー別
- 診断センターにおける市場規模
- 病院における市場規模
- 乳房治療センターにおける市場規模
・世界の乳房画像市場規模:地域別
- 南北アメリカの乳房画像市場規模
アメリカの乳房画像市場規模
カナダの乳房画像市場規模
ブラジルの乳房画像市場規模
...
- アジア太平洋の乳房画像市場規模
日本の乳房画像市場規模
中国の乳房画像市場規模
インドの乳房画像市場規模
韓国の乳房画像市場規模
台湾の乳房画像市場規模
...
- ヨーロッパ/中東/アフリカの乳房画像市場規模
イギリスの乳房画像市場規模
ドイツの乳房画像市場規模
インドの乳房画像市場規模
フランスの乳房画像市場規模
ロシアの乳房画像市場規模
...
- その他地域の乳房画像市場規模

・競争状況
・企業情報

The Global Breast Imaging Market size was estimated at USD 4,120.18 million in 2021 and expected to reach USD 4,483.94 million in 2022, and is projected to grow at a CAGR 9.00% to reach USD 6,912.12 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Breast Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Ionizing Breast Imaging Technology and Non-Ionizing Breast Imaging Technology. The Ionizing Breast Imaging Technology is further studied across 3D Breast Tomosynthesis, Analog Mammography, Cone Beam Computed Tomography, Full-Field Digital Mammography, Molecular Breast Imaging/Breast-Specific Gamma Imaging, Positron Emission Mammography, and Positron Emission Tomography/Computed Tomography. The Non-Ionizing Breast Imaging Technology is further studied across Automated Whole Breast Ultrasound, Breast MRI, Breast Thermography, Breast Ultrasound, and Optical Imaging.

Based on End User, the market was studied across Diagnostic Center, Hospital, and Breast Care Center.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Breast Imaging market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Breast Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Breast Imaging Market, including Aurora Imaging Technology, Inc., CMR Naviscan Corporation, Delphinus Medical Technologies, Inc., Dilon Technologies, Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., KUB Technologies Inc., Micrima Limited, Philips Healthcare, Planmed Oy, Shimadzu Corporation, Siemens Healthineers AG, Sonociné, Inc., and SuperSonic Imagine SA.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Breast Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Breast Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Breast Imaging Market?
4. What is the competitive strategic window for opportunities in the Global Breast Imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Breast Imaging Market?
6. What is the market share of the leading vendors in the Global Breast Imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Breast Imaging Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for early detection of breast cancer
5.1.1.2. Practical advantages and patient convenience associated with digital mammography
5.1.1.3. Proactive initiative by government and healthcare organization to raise awareness
5.1.1.4. Increasing investment and collaborative ecosystem
5.1.2. Restraints
5.1.2.1. Patient inconvenience, false positives, over-diagnosis, and over-treatment associated with breast cancer screening
5.1.3. Opportunities
5.1.3.1. Technology advancements and the complimentary products
5.1.3.2. Potential in emerging economies due to increasing awareness and supporting infrastructure
5.1.4. Challenges
5.1.4.1. High cost associated with the modalities
5.2. Cumulative Impact of COVID-19

6. Breast Imaging Market, by Technology
6.1. Introduction
6.2. Ionizing Breast Imaging Technology
6.3.1. 3D Breast Tomosynthesis
6.3.2. Analog Mammography
6.3.3. Cone Beam Computed Tomography
6.3.4. Full-Field Digital Mammography
6.3.5. Molecular Breast Imaging/Breast-Specific Gamma Imaging
6.3.6. Positron Emission Mammography
6.3.7. Positron Emission Tomography/Computed Tomography
6.3. Non-Ionizing Breast Imaging Technology
6.4.1. Automated Whole Breast Ultrasound
6.4.2. Breast MRI
6.4.3. Breast Thermography
6.4.4. Breast Ultrasound
6.4.5. Optical Imaging

7. Breast Imaging Market, by End User
7.1. Introduction
7.2. Diagnostic Center
7.3. Hospital
7.4. Breast Care Center

8. Americas Breast Imaging Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Breast Imaging Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Breast Imaging Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Aurora Imaging Technology, Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. CMR Naviscan Corporation
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Delphinus Medical Technologies, Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Dilon Technologies, Inc.
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Fujifilm Holdings Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. GE Healthcare
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Hologic, Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. KUB Technologies Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Micrima Limited
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Philips Healthcare
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Planmed Oy
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Shimadzu Corporation
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Siemens Healthineers AG
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Sonociné, Inc.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. SuperSonic Imagine SA
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing